SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Wells Fargo Maintains Overweight on Global Blood Therapeutics, Raises Price Target to $133

Wells Fargo maintains Global Blood Therapeutics (NASDAQ:GBT) with a Overweight and raises the price target from $122 to $133.

Benzinga · 05/07/2020 13:50

Wells Fargo maintains Global Blood Therapeutics (NASDAQ:GBT) with a Overweight and raises the price target from $122 to $133.